§ 316.4. Address for submissions.
45 words·~1 min read·
/us/cfr/t21/s§ 316.4·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
All correspondence and requests for FDA action under the provisions of this rule should be addressed as follows: Office of Orphan Products Development, Food and Drug Administration, Bldg. 32, Rm. 5271, 10903 New Hampshire Ave., Silver Spring, MD 20993. [78 FR 35133, June 12, 2013]